BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17616859)

  • 1. New protocol of clomiphene citrate treatment in women with hypothalamic amenorrhea.
    Borges LE; Morgante G; Musacchio MC; Petraglia F; De Leo V
    Gynecol Endocrinol; 2007 Jun; 23(6):343-6. PubMed ID: 17616859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of every-other-day administration of gonadotropin-releasing hormone in women with hypothalamic amenorrhea: gonadotropin-releasing hormone treatment can induce clomiphene responsiveness.
    Kotsuji F; Aso T; Kamitani N; Tominaga T; Kitaguchi M; Okamura Y
    Obstet Gynecol; 1988 Apr; 71(4):615-21. PubMed ID: 3281077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conception rates in clomiphene citrate cycles with and without hormone supplementation: a pilot study.
    Elkind-Hirsch KE; Darensbourg C; Creasy G; Gipe D
    Curr Med Res Opin; 2005 Jul; 21(7):1035-40. PubMed ID: 16004670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovulation induction by the chronic administration of naltrexone in a patient with secondary hypothalamic amenorrhea].
    Sir T; Alba F; Rivera J; Kohen P; Devoto L
    Rev Chil Obstet Ginecol; 1992; 57(1):39-43. PubMed ID: 1342427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone in functional hypothalamic amenorrhea and in the normal luteal phase.
    Remorgida V; Venturini PL; Anserini P; Salerno E; De Cecco L
    Obstet Gynecol; 1990 Dec; 76(6):1115-20. PubMed ID: 2122343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin.
    Mendes MC; Ferriani RA; Sala MM; Moura MD; de Sá MF
    Gynecol Endocrinol; 1999 Jun; 13(3):149-54. PubMed ID: 10451805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Favorable reproductive and menstrual evolution in adult women, who presented in the adolescence, menstrual disturbances by hypothalamic dysfunction and lack of response to clomiphene].
    Devoto E; Aravena L
    Rev Med Chil; 2002 Jul; 130(7):745-52. PubMed ID: 12235898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study.
    Panay N; Pritsch M; Alt J
    Gynecol Endocrinol; 2007 Nov; 23(11):611-8. PubMed ID: 17891596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of a long-term clomiphene citrate therapy in women with normogonadotropic menstrual disturbanes (author's transl)].
    Schmid R; Leodolter S; Müller-Tyl E; Philipp K; Schneider WH
    Wien Klin Wochenschr; 1979 Feb; 91(4):122-5. PubMed ID: 425531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of the menstrual cycle after discontinuation of oral contraceptives.
    Duijkers I; Engels L; Klipping C
    Gynecol Endocrinol; 2005 Feb; 20(2):74-9. PubMed ID: 15823825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea.
    De Leo V; la Marca A; Lanzetta D; Morgante G
    Eur J Obstet Gynecol Reprod Biol; 2000 May; 90(1):103-8. PubMed ID: 10767520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clomiphene acetate and prednisone: alternative approach for the management of patients with chronic anovulation and clomiphene treatment failure].
    Vital Reyes VS; Tellez Velasco S; Hinojosa Cruz JC; Reyes Fuentes A
    Ginecol Obstet Mex; 2000 Jun; 68():266-70. PubMed ID: 10939196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual dysfunction following use of oral contraceptives.
    Homesley HD; Goss DA
    Obstet Gynecol; 1970 May; 35(5):734-9. PubMed ID: 5441266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of amenorrhea in the adolescent.
    Golden NH; Carlson JL
    Ann N Y Acad Sci; 2008; 1135():163-78. PubMed ID: 18574222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
    Wildt L; Leyendecker G
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1334-5. PubMed ID: 3571432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of a new regimen with clomiphene citrate administration to reduce the antiestrogenic effects on reproductive end organs.
    Kelekçi S; Saygili-Yilmaz E; Inan I; Eminsoy G
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):54-7. PubMed ID: 15294368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles.
    Dovey S; Sneeringer RM; Penzias AS
    Fertil Steril; 2008 Dec; 90(6):2281-6. PubMed ID: 18191842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of the biochemical response to clomiphene citrate for the selection of women with hypothalamic amenorrhea who require further investigation.
    Corenblum B; Taylor PJ
    Fertil Steril; 1987 Nov; 48(5):766-9. PubMed ID: 2959568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future recovery of the normal menstrual cycle in adolescent patients with secondary amenorrhea.
    Morimatsu Y; Matsubara S; Watanabe T; Hashimoto Y; Matsui T; Asada K; Suzuki M
    J Obstet Gynaecol Res; 2009 Jun; 35(3):545-50. PubMed ID: 19527397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.